Vascular News and Research

RSS

Air pollution can cause serious health consequences to more than 600 million people in South Asia

With another smoggy winter hanging over the vast and thickly populated Indo-Gangetic plains, there are fears of serious health consequences to more than 600 million people living in northern India and Nepal as well as in eastern Pakistan and Bangladesh.

13 Dec 2021

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Physicians treating coronavirus infections have a new diagnostic that could help identify patients at risk of organ failure.

13 Dec 2021

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

A new study demonstrates lethal infection of the olfactory epithelium in a mouse model that could help understand the mechanisms of COVID-19.

12 Dec 2021

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.

10 Dec 2021

Study measures arterial stiffness in women from wide age range

A study conducted at the University of Jyväskylä in the Faculty of Sport and Health Sciences measured arterial stiffness in women from wide age range.

10 Dec 2021

Regular aerobic exercise during midlife may prevent age-related chronic diseases

Middle-aged endurance athletes have better control of blood pressure and higher arterial elasticity (a noninvasive measure of cardiovascular risk) than sedentary adults in the same age group.

9 Dec 2021

Environmental exposure to low-levels of toxic metals may increase risk of clogged arteries

Environmental exposure to low-levels of the toxic metals arsenic, cadmium and titanium appears to increase the risk of plaque buildup in arteries in the neck, heart and legs, according to new research published today in the American Heart Association's journal Arteriosclerosis, Thrombosis and Vascular Biology (ATVB).

9 Dec 2021

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

Scientists have discovered that gene therapy and the diabetes drug metformin may be potential treatments for late-onset retinal degeneration (L-ORD), a rare, blinding eye disease.

9 Dec 2021

High-dose intravenous iron reduces heart attacks in hemodialysis patients

A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis.

8 Dec 2021

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Researchers examined autopsy tissue samples of hearts from patients who died early in the COVID-19 pandemic.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

New self-administered test can find the early subtle signs of dementia sooner

Many people experience forgetfulness as they age, but it's often difficult to tell if these memory issues are a normal part of aging or a sign of something more serious

7 Dec 2021

New therapeutic targets for the treatment and prevention of hypertension, cardiovascular diseases

Cardiovascular diseases are the leading cause of death worldwide. Although the development of these disorders is most commonly associated with lifestyle factors like obesity, increasing evidence suggests that events much earlier in one's life can also play a role.

6 Dec 2021

Study analyzes global COVID-19 vaccination rates among people living with HIV

COVID-19 vaccination is especially important for immunocompromised individuals, such as people living with HIV, who face higher risks of developing severe symptoms and dying from COVID-19.

1 Dec 2021

Fast-tracked human stroke drug may also be a safe and powerful defense against dementia

A human stroke drug, fast-tracked by the Food and Drug Administration and soon entering Phase 3 clinical trials, shows intriguing signs that it might also be a safe and powerful defense against Alzheimer's and other forms of dementia.

1 Dec 2021

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

A research team at the University of Córdoba is studying the alterations that occur in the immune system's T lymphocytes with respect to age and in relation to the cytomegalovirus herpesvirus.

29 Nov 2021

Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by investigators from Dana-Farber Cancer Institute.

25 Nov 2021

New therapeutic approach prevents growth of metastatic tumors by putting cancer cells to sleep

A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate.

23 Nov 2021

Novel protein regulator of tumor angiogenesis may be a therapeutic target for difficult-to-treat cancers

A novel protein regulator of tumor angiogenesis, TMEM230, was recently characterized by researchers to have a role in tumor development and vascularization, with potential as a target for anti-tumor therapy in difficult-to-treat cancers such as glioblastoma.

23 Nov 2021

Examining the effects of malaria parasites on global health

News-Medical speaks to Professor Kevin Baird about his lifelong research into malaria and how another malaria parasite, P. Vivax, is taking a toll on global health.

22 Nov 2021

Vascular News and Research

Air pollution can cause serious health consequences to more than 600 million people in South Asia

New technology could help determine COVID-19 patients at risk for micro thrombosis-related issues

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

New insights about COVID-19 vaccination rates among people living with HIV

Study measures arterial stiffness in women from wide age range

Regular aerobic exercise during midlife may prevent age-related chronic diseases

Environmental exposure to low-levels of toxic metals may increase risk of clogged arteries

Gene therapy and diabetes drug may be treatments for late-onset retinal degeneration

High-dose intravenous iron reduces heart attacks in hemodialysis patients

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

New self-administered test can find the early subtle signs of dementia sooner

New therapeutic targets for the treatment and prevention of hypertension, cardiovascular diseases

Study analyzes global COVID-19 vaccination rates among people living with HIV

Fast-tracked human stroke drug may also be a safe and powerful defense against dementia

Cytomegalovirus herpesvirus can accelerate the decline of the immune system, study finds

Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

New therapeutic approach prevents growth of metastatic tumors by putting cancer cells to sleep

Novel protein regulator of tumor angiogenesis may be a therapeutic target for difficult-to-treat cancers

Examining the effects of malaria parasites on global health

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News